A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors

Clinical trial NCT06773091 · RECRUITING

Trial details

NCT number: NCT06773091
Sponsor: Shanghai NK Cell Technology Co., LTD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-02-07
Primary completion: 2026-12-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.